AI-Driven Patient Monitor Relies On Biosensor Data

A major player in AI-driven digital medicine, physIQ’s pinpointIQ solution is an end-to-end ambulatory monitoring solution that applies machine learning analytics to continuous patient data streams from wearable sensors to improve care and support clinicians tasked with managing large, complex post-acute populations. Credited as the first personalized multivariate analytics engine to receive FDA 510k clearance, the pinpointIQ solution collects continuous physiological patient data from wearable biosensors and applies artificial intelligence-based analytics to detect subtle changes in a patient’s vital sign patterns.

 

The continuous and near real-time nature of the solution allows healthcare enterprises to proactively manage care and identify personalized changes that may be a precursor to an acute care event. The data- and device-agnostic physIQ platform can accommodate any Bluetooth-enabled biosensor and has been engineered to be highly scalable and capable of continuously monitoring large patient populations. The care team user interface enables drill-down functionality into physiology data for each patient and at-a-glance visibility across the monitored patient population. If this piques your curiosity, feel free to digest more diagnoses.

Sponsored by Anritsu Company

New VNA technologies enable mmWave broadband testing to 220 GHz, helping researchers and engineers to overcome test challenges and simplify mmWave testing.

Application development in the mmWave frequencies is growing. Broadband testing over hundreds of GHz of bandwidth is subject to repeatability/accuracy deficits, and engineers demand solutions to help overcome challenges and simplify mmWave testing.

Suggested Articles

Broadly, Goldman Sachs believes U.S. companies will see no earnings growth in 2020

Supply chain slowdown in China affects Windows OEM and Surface

Coronavirus to cause $70 million reduction in revenues for 2Q